Mariner’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86.7M Sell
621,970
-42,360
-6% -$5.93M 0.1% 169
2025
Q4
$81.5M Buy
664,330
+42,089
+7% +$5.11M 0.1% 169
2025
Q3
$69.1M Buy
622,241
+11,153
+2% +$1.27M 0.09% 188
2025
Q2
$67.8M Buy
611,088
+31,983
+6% +$3.4M 0.1% 183
2025
Q1
$64.9M Buy
579,105
+28,580
+5% +$2.95M 0.11% 170
2024
Q4
$50.9M Buy
550,525
+34,541
+7% +$3.11M 0.09% 204
2024
Q3
$43.3M Buy
515,984
+26,480
+5% +$2.02M 0.08% 227
2024
Q2
$33.6M Buy
489,504
+6,767
+1% +$452K 0.07% 247
2024
Q1
$35.4M Buy
482,737
+312,496
+184% +$24M 0.07% 232
2023
Q4
$13.8M Sell
170,241
-1,588
-0.9% -$124K 0.03% 386
2023
Q3
$12.9M Buy
171,829
+1,191
+0.7% +$91.6K 0.03% 370
2023
Q2
$13.1M Sell
170,638
-10,832
-6% -$864K 0.04% 371
2023
Q1
$15M Sell
181,470
-10,532
-5% -$872K 0.04% 339
2022
Q4
$16.5M Buy
192,002
+40,339
+27% +$3.19M 0.05% 311
2022
Q3
$9.36M Buy
151,663
+37,667
+33% +$2.38M 0.04% 357
2022
Q2
$7.05M Buy
113,996
+11,260
+11% +$697K 0.03% 400
2022
Q1
$6.11M Buy
102,736
+4,318
+4% +$276K 0.02% 447
2021
Q4
$7.15M Buy
98,418
+7,467
+8% +$514K 0.03% 372
2021
Q3
$6.35M Buy
90,951
+2,524
+3% +$177K 0.03% 327
2021
Q2
$6.09M Buy
88,427
+8,715
+11% +$582K 0.04% 302
2021
Q1
$5.15M Sell
79,712
-6,358
-7% -$410K 0.04% 304
2020
Q4
$5.01M Sell
86,070
-191,781
-69% -$11.6M 0.04% 290
2020
Q3
$17.6M Buy
277,851
+49,469
+22% +$3.43M 0.17% 148
2020
Q2
$17.6M Buy
228,382
+73,643
+48% +$5.64M 0.18% 143
2020
Q1
$11.6M Buy
154,739
+22,238
+17% +$1.54M 0.14% 159
2019
Q4
$8.61M Buy
132,501
+14,671
+12% +$955K 0.09% 202
2019
Q3
$7.47M Sell
117,830
-15,154
-11% -$991K 0.09% 198
2019
Q2
$8.98M Sell
132,984
-454
-0.3% -$29.9K 0.11% 185
2019
Q1
$8.68M Buy
133,438
+24,960
+23% +$1.66M 0.12% 175
2018
Q4
$6.79M Buy
108,478
+7,636
+8% +$534K 0.12% 179
2018
Q3
$7.79M Buy
100,842
+10,461
+12% +$790K 0.2% 121
2018
Q2
$6.4M Buy
90,381
+13,808
+18% +$975K 0.18% 128
2018
Q1
$5.77M Buy
76,573
+51,674
+208% +$4.11M 0.21% 102
2017
Q4
$1.78M Sell
24,899
-26,644
-52% -$2.02M 0.07% 220
2017
Q3
$4.18M Sell
51,543
-4,553
-8% -$348K 0.19% 100
2017
Q2
$3.97M Buy
56,096
+2,265
+4% +$151K 0.19% 99
2017
Q1
$3.66M Buy
53,831
+1,217
+2% +$85.6K 0.16% 119
2016
Q4
$3.77M Buy
52,614
+837
+2% +$62.2K 0.17% 112
2016
Q3
$4.1M Buy
51,777
+3,438
+7% +$279K 0.2% 98
2016
Q2
$4.03M Buy
48,339
+889
+2% +$78.9K 0.22% 101
2016
Q1
$4.36M Buy
47,450
+6,092
+15% +$549K 0.26% 76
2015
Q4
$4.18M Sell
41,358
-9,199
-18% -$957K 0.27% 82
2015
Q3
$4.96M Buy
50,557
+1,165
+2% +$129K 0.22% 100
2015
Q2
$5.78M Buy
49,392
+22,820
+86% +$2.49M 0.27% 97
2015
Q1
$2.61M Buy
26,572
+2,999
+13% +$305K 0.22% 84
2014
Q4
$2.22M Sell
23,573
-3,610
-13% -$373K 0.2% 90
2014
Q3
$2.89M Sell
27,183
-917
-3% -$89.8K 0.33% 52
2014
Q2
$2.33M Sell
28,100
-10,374
-27% -$807K 0.26% 78
2014
Q1
$2.73M Buy
38,474
+7,208
+23% +$565K 0.35% 58
2013
Q4
$2.35M Buy
31,266
+12,202
+64% +$850K 0.29% 74
2013
Q3
$1.2M Buy
19,064
+5,907
+45% +$353K 0.22% 109
2013
Q2
$675K Buy
+13,157
New +$686K 0.14% 146

Other funds holding GILD

Mariner's GILD Position: Q1 2026 in Review

Mariner reduced its Gilead Sciences (GILD) stake by 6.4% in Q1 2026, selling an estimated $5.93M and leaving 621,970 shares worth $86.7M. The position accounts for 0.1% of the portfolio, ranked #169.

Mariner first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mariner held 621,970 shares of Gilead Sciences worth $86.7M as of Q1 2026.
  • Mariner sold 42,360 Gilead Sciences shares in Q1 2026, an estimated $5.93M.
  • Gilead Sciences made up 0.1% of Mariner's portfolio in Q1 2026, its #169 holding.
  • Mariner first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.